The Venture Codex Logo

The Venture Codex

Boston Children's Hospital

300 Longwood Ave., Boston, MA, 02115, United States

Overview

Boston Children's Hospital provides pediatric health care services. The hospital provides surgical, radiological examination, and clinical and cancer research services. Additionally, it offers diabetes, endocrinology, gastroenterology, urology, neonatology, orthopedics, and pulmonology healthcare services. The hospital also provides community service programs and postdoctoral training services. Boston Children's Hospital was founded in 1869 and is based in Boston, Massachusetts. Boston Children's Hospital operates as a subsidiary of Children's Medical Center Corporation.

Total investments
4
Lead investments
0
Investments · 12mo
0
Active investors
8

Sector focus

  • Biotechnology
  • Health Care
  • Medical
  • Oncology
Visit website

Investment portfolio

  • Brightline

    Participated · Series C · Apr 2022

    Brightline delivers virtual behavioral health services built specifically for children, teenagers, and their families, using multidisciplinary care teams and evidence-based programs. The company emphasizes a family-focused approach and provides care across a broad range of needs nationwide. Brightline plans to expand access to care by coordinating with ecosystem partners for specialized care and by innovating its care model with interactive content interventions and expanded care modalities. It also intends to develop next-generation employee benefits and grow tailor-made services for teenagers. Led by CEO Naomi Allen, Brightline brings care to families when and where they need it. Financially, the company has been raising venture capital, most recently through its Series C financing. Brightline is a virtual behavioral health solution built specifically to care for children, teenagers, and their families, offering a digital on-demand platform called Connect alongside coaching programs and clinical services. Its clinical offerings include behavioral therapy, evaluation, medication support, and speech therapy, and its services are available in all 50 states. Brightline partners with health plans and employers, including Aetna, Blue Cross Blue Shield of Massachusetts, Blue Shield of California, Sequoia, Stanford University, and others, and currently serves 50 employers. The company covers over 24 million health plan lives and had plans to reach more than 50 million health plan lives in 2022. After raising a $105M Series C, bringing total funding to over $200M, Brightline intends to expand operations and business reach and continue providing employee benefits. It plans to innovate its care model with interactive content and expanded care modalities and to expand tailored services for teens and specialty programs supporting caregivers of children with Autism Spectrum Disorder and youth who identify as LGBTQ+ and/or BIPOC. Brightline provides technology-enabled behavioral health care specifically for children, teens, and their families, delivered via multidisciplinary care teams and a family-focused, evidence-based model. The company combines clinical care with innovative technology to address a range of common pediatric behavioral health challenges. Led by CEO and co-founder Naomi Allen with co-founder Giovanni Colella, MD, Brightline was founded in 2019 and is based in Palo Alto, CA. Its care model emphasizes family-centered approaches and multidisciplinary teams. Brightline intends to use the new funding to scale care across the country. Financially, the company has now raised nearly $100 million to date. Brightline delivers integrated, technology-enabled pediatric behavioral health services through virtual care and a mobile app, offering behavior therapy, psychiatry, speech-language therapy, parent coaching, clinician-led classes, and digital treatment programs. The company launched four months ahead of schedule during the COVID-19 pandemic to expand urgently needed telehealth services to families. Brightline plans to expand telehealth capabilities and treatment programs, enhance its technology and innovations, and grow its team to support children and families across additional states. The company announced a $20 million Series A to support those efforts. Brightline emphasizes a cross-disciplinary, family-focused model with integrated clinical teams and coaching support for parents. Founded in 2019 and headquartered in Palo Alto, CA, Brightline was started by Naomi Allen and Giovanni Colella. Emilio Health combines in-person, child-centered clinics with a digital platform for scheduling, progress tracking, and tele-therapy to simplify behavioral health care for children and caregivers. The company deploys multidisciplinary teams, clinically validated treatment plans, and a collaborative care model that connects therapists, physicians, families, and schools. Emilio targets the roughly 17 million U.S. children who suffer from behavioral health issues and emphasizes improving access, coordination, and quality of care. The platform is coach-enabled and intended to support families across developmental stages with both in-person and virtual interventions. The company plans to launch its first clinics and its digital platform using proceeds from the seed round and to continue building its leadership team. Emilio was founded in 2019 and is headquartered in Palo Alto, CA.

  • Circulation

    Participated · Series A · Jul 2017

    Circulation, incubated by Klick Health, offers a platform focused on healthcare transportation and improving appointment adherence. The company reported significant growth and momentum, serving almost 50 clients across 1,000 top‑tier hospitals, clinics, community health centers, and other healthcare facilities nationwide. Circulation says it has delivered measurable improvements in cost savings, patient satisfaction, and appointment adherence. Klick Health leadership praised the team and reaffirmed its role as a commercialization partner. The company counts co‑founders John Brownstein, Robin Heffernan, and Jared Hawkins. Circulation also announced new strategic alliances alongside its financing close.

  • Claritas Genomics

    Participated · Series B · Jan 2015

    Claritas Genomics provides clinical genetic diagnostic testing using next-generation sequencing and a network of pediatric disease specialists to support clinicians. The company combines clinical expertise of pediatric specialists with sequencing technology to offer a range of diagnostic services. It plans to expand commercial operations and launch new sequencing-based tests for diagnosis of pediatric genetic disorders. Claritas also intends to continue building its network of clinical pediatric disease experts. The company is led by CEO Patrice Milos, Ph.D.

Team

  • David Williams

    Chief of the Division of Hematology/Oncology

  • Pedro del Nido

    Chief Cardiac Surgery

    LinkedIn
  • Howard Shane

    Director, Center for Communication Enhancement

    LinkedIn
  • Salim Afshar

    Oral & Maxillofacial Surgeon

    LinkedIn